S-1: Banzai International Files for Resale of Common Stock and Warrants
Registration Statement
Banzai International is filing a prospectus for the resale of shares of Class A Common Stock and warrants by selling securityholders.
Summary
- Banzai International has filed a registration statement for the resale of up to 613,269 shares of Class A Common Stock, 2,279,271 shares of Class A Common Stock underlying Convertible Notes, common warrants to purchase up to 1,896,893 shares of Class A Common Stock, and pre-funded warrants to purchase up to 1,353,624 shares of Class A Common Stock.
- The selling securityholders may offer these shares publicly or through private transactions at prevailing market prices or negotiated prices.
- Banzai will not receive any proceeds from the sale of these shares by the selling securityholders, but will receive the exercise price of any pre-funded warrants ($0.001 per share) and Series A warrants ($39.24 per share) exercised for cash.
- The company will pay the expenses associated with the sale of securities, excluding underwriting discounts and commissions and expenses incurred by the Selling Securityholder for brokerage, accounting, tax or legal services or any other expenses incurred by the Selling Securityholder in disposing of the securities.
- The company's Class A Common Stock is listed on The Nasdaq Global Market under the symbol BNZI, with a last reported sale price of $5.69 per share on September 20, 2024.
- The company is awaiting a decision from The Nasdaq Hearings Panel regarding compliance with listing requirements.
Sentiment
Score: 5
Explanation: The document is neutral, primarily focused on the mechanics of a securities offering and related agreements. There is no strong positive or negative sentiment expressed.
Negatives
- The company will not receive any proceeds from the sale of shares of Class A Common Stock by the Selling Securityholder.
- Sales of a substantial number of shares of Class A Common Stock in the public market, including the resale of the shares of Class A Common Stock held by our stockholders pursuant to this prospectus or pursuant to Rule 144, could occur at any time.
- These sales, or the perception in the market that the holders of a large number of shares of Class A Common Stock intend to sell shares, could reduce the market price of the Class A Common Stock and make it more difficult for you to sell your holdings at times and prices that you determine are appropriate.
- There can be no assurance that the Panel will grant the Company an additional extension period or that the Company will ultimately regain compliance with all applicable requirements for continued listing on The Nasdaq Global Market.
Risks
- Sales of a substantial number of shares of Class A Common Stock in the public market, including the resale of the shares of Class A Common Stock held by our stockholders pursuant to this prospectus or pursuant to Rule 144, could occur at any time.
- These sales, or the perception in the market that the holders of a large number of shares of Class A Common Stock intend to sell shares, could reduce the market price of the Class A Common Stock and make it more difficult for you to sell your holdings at times and prices that you determine are appropriate.
- There can be no assurance that the Panel will grant the Company an additional extension period or that the Company will ultimately regain compliance with all applicable requirements for continued listing on The Nasdaq Global Market.
Future Outlook
The selling securityholder will continue to offer the securities covered by this prospectus or pursuant to Rule 144 for a significant period of time, the precise duration of which cannot be predicted.
Industry Context
The document relates to the MarTech industry, where companies are increasingly relying on digital channels and data-driven marketing strategies.
Related Party Transactions
- The document mentions several related party transactions, including loans and share transfer agreements with Alco Investment Company and the Sponsor.
Stakeholder Impact
- The resale of a substantial number of shares could reduce the market price of the Class A Common Stock, impacting current shareholders.
- The outcome of the Nasdaq Hearings Panel decision will affect the company's listing status and investor confidence.
Next Steps
- The selling securityholders may offer, sell or distribute all or a portion of their shares of Class A Common Stock publicly or through private transactions at prevailing market prices or at negotiated prices.
- The Company will continue to trade on The Nasdaq Global Market until the hearing process concludes and the Panel issues a written decision.
Key Dates
| Date | Description |
|---|---|
| 2020-12-22 | Date of the Warrant Agreement between 7GC and Continental Stock Transfer & Trust Company. |
| 2022-12-08 | Date of the Original Merger Agreement between Banzai and 7GC. |
| 2023-08-04 | Date of the Merger Agreement Amendment between Banzai and 7GC. |
| 2023-09-13 | Date of the September Alco Note issuance. |
| 2023-11-16 | Date of the November Alco Note issuance. |
| 2023-12-13 | Date of the December Alco Note issuance and GEM Term Sheet. |
| 2023-12-14 | Closing Date of the Business Combination, GEM Letter, and Original SEPA. |
| 2023-12-15 | Date of GEM Warrant issuance. |
| 2024-02-02 | Date of Roth Addendum and issuance of Roth Shares. |
| 2024-02-05 | Date of SEPA Supplemental Agreement and GEM Settlement Agreement. |
| 2024-05-22 | Date of pricing for the best efforts public offering and Amended Debt Repayment Agreement. |
| 2024-05-28 | Closing date of the best efforts public offering. |
| 2024-08-06 | Date of Nasdaq notice regarding failure to comply with MVLS requirement. |
| 2024-09-10 | Board determined to effect a reverse stock split at a ratio of 1-for-50. |
| 2024-09-16 | Date of Nasdaq letter regarding Bid Price Deficiency. |
| 2024-09-19 | Hearing before The Nasdaq Hearings Panel. |
| 2024-09-20 | Date of share information. |
| 2024-09-23 | Date of CP BF SPA and Amended Loan Agreement. |
Keywords
Class A Common Stock, warrants, resale, Banzai International, selling securityholders, registration statement, convertible notes
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.